Tuberculosis: a new vision for the 21st century.

Kekkaku : [Tuberculosis]

Volumn 84, Issue 11, 2009, Pages 721-726

  Small, Peter M ^a  

^a BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

ARTICLE; COST BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FORECASTING; HEALTH; HUMAN; INFECTION CONTROL; MULTIDRUG RESISTANT TUBERCULOSIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; COST-BENEFIT ANALYSIS; DIRECTLY OBSERVED THERAPY; FORECASTING; HUMANS; TUBERCULOSIS; TUBERCULOSIS VACCINES; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH;

EID: 77449084096     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)